propranolol has been researched along with 7-hydroxycoumarin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Beaufils, F; Bohnacker, T; Borsari, C; Cmiljanovic, N; Cmiljanovic, V; Fabbro, D; Giese, B; Hebeisen, P; Hillmann, P; Jackson, E; Marone, R; Melone, A; Mestan, J; Rageot, D; Sele, A; Williams, RL; Wymann, MP; Zhang, X; Zvelebil, M | 1 |
| Basetti, V; Keesara, M; Maiti, P; Mansour, TS; Moghudula, AG; Pallepati, RR; Potluri, V | 1 |
| Beaufils, F; Bohnacker, T; Borsari, C; Burke, JE; Fabbro, D; Hebeisen, P; Hillmann, P; Hoffmann, RM; Keles, E; McPhail, JA; Melone, A; Rageot, D; Sele, AM; Sriramaratnam, R; Wymann, MP | 1 |
1 review(s) available for propranolol and 7-hydroxycoumarin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
3 other study(ies) available for propranolol and 7-hydroxycoumarin
| Article | Year |
|---|---|
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
Topics: Administration, Oral; Aminopyridines; Animals; Antineoplastic Agents; Brain; Cell Proliferation; Dogs; Humans; Mice; Models, Molecular; Morpholines; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Rats; Rats, Nude; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |
Lead generation of 1,2-dithiolanes as exon 19 and exon 21 mutant EGFR tyrosine kinase inhibitors.
Topics: Exons; Humans; Mutation; Protein Kinase Inhibitors; Thioctic Acid | 2019 |
(
Topics: Aminopyridines; Animals; Antineoplastic Agents; Brain; Cell Line, Tumor; Dogs; Female; Humans; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Binding; Pyridines; Rats, Wistar; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Triazines; Xenograft Model Antitumor Assays | 2019 |